Current Neuropharmacology

Papers
(The median citation count of Current Neuropharmacology is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer’s Disease219
Role of Nuclear Factor Kappa B (NF-κB) Signalling in Neurodegenerative Diseases: An Mechanistic Approach113
Crosstalk between Inflammation and the BBB in Stroke70
Angiogenesis and Blood-Brain Barrier Permeability in Vascular Remodeling after Stroke65
Molecular Hybridization as a Tool in the Design of Multi-target Directed Drug Candidates for Neurodegenerative Diseases63
A Scientometrics Analysis and Visualization of Depressive Disorder53
Understanding the Role of Histone Deacetylase and their Inhibitors in Neurodegenerative Disorders: Current Targets and Future Perspective52
‘New/Designer Benzodiazepines’: An Analysis of the Literature and Psychonauts’ Trip Reports46
Alzheimer’s Disorder: Epigenetic Connection and Associated Risk Factors46
The Potential Role of Dysfunctions in Neuron-Microglia Communication in the Pathogenesis of Brain Disorders45
Ultramicronized Palmitoylethanolamide and Luteolin Supplement Combined with Olfactory Training to Treat Post-COVID-19 Olfactory Impairment: A Multi-Center Double-Blinded Randomized Placebo- Controlled45
Role of Nitric Oxide in Neurodegeneration: Function, Regulation, and Inhibition45
Role of Oxidative Stress and Metal Toxicity in the Progression of Alzheimer’s Disease41
Selenium and Neurological Diseases: Focus on Peripheral Pain and TRP Channels41
The Dual Role of Microglia in Blood-Brain Barrier Dysfunction after Stroke40
Effects of Withania somnifera (Ashwagandha) on Stress and the Stress- Related Neuropsychiatric Disorders Anxiety, Depression, and Insomnia39
Temozolomide: An Updated Overview of Resistance Mechanisms, Nanotechnology Advances and Clinical Applications37
Mitochondrion as a Selective Target for the Treatment of Atherosclerosis: Role of Mitochondrial DNA Mutations and Defective Mitophagy in the Pathogenesis of Atherosclerosis and Chronic Inflammation37
The Multifaceted Therapeutic Role of N-Acetylcysteine (NAC) in Disorders Characterized by Oxidative Stress37
The Stroke-Induced Blood-Brain Barrier Disruption: Current Progress of Inspection Technique, Mechanism, and Therapeutic Target35
The Critical Period for Neuroprotection by Estrogen Replacement Therapy and the Potential Underlying Mechanisms34
PTSD in the COVID-19 Era33
Potential Mechanisms and Clinical Effectiveness of Acupuncture in Depression32
Exosomes as a Promising Therapeutic Strategy for Peripheral Nerve Injury32
The Role of Autophagy in the Pathogenesis of Ischemic Stroke31
Neuroprotective Polyphenols: A Modulatory Action on Neurotransmitter Pathways31
Drug Choices and Advancements for Managing Depression in Parkinson's Disease30
A New Vision of Mitochondrial Unfolded Protein Response to the Sirtuin Family30
Chinese Herbal Medicine Interventions in Neurological Disorder Therapeutics by Regulating Glutamate Signaling29
5-HT3 Receptor Antagonism: A Potential Therapeutic Approach for the Treatment of Depression and other Disorders28
Dysregulation of the Gut-Brain Axis, Dysbiosis and Influence of Numerous Factors on Gut Microbiota Associated Parkinson’s Disease28
Pre-clinical to Clinical Translational Failures and Current Status of Clinical Trials in Stroke Therapy: A Brief Review28
The Effects of General Anesthetics on Synaptic Transmission27
C-Phycocyanin-derived Phycocyanobilin as a Potential Nutraceutical Approach for Major Neurodegenerative Disorders and COVID-19- induced Damage to the Nervous System26
Mitochondrial Dysfunction in Alzheimer’s Disease: Opportunities for Drug Development26
Recent Evidence in Epigenomics and Proteomics Biomarkers for Early and Minimally Invasive Diagnosis of Alzheimer’s and Parkinson’s Diseases26
Management Perspective of Wilson’s Disease: Early Diagnosis and Individualized Therapy26
Glia-Driven Neuroinflammation and Systemic Inflammation in Alzheimer’s Disease26
Off-label Uses of Selective Serotonin Reuptake Inhibitors (SSRIs)26
Underlying Mechanisms and Potential Therapeutic Molecular Targets in Blood-Brain Barrier Disruption after Subarachnoid Hemorrhage26
Therapeutic and Mechanistic Effects of Curcumin in Huntington’s Disease25
The Role of Mitochondrial Impairment in Alzheimer´s Disease Neurodegeneration: The Tau Connection25
Neuroinflammatory Signaling in the Pathogenesis of Alzheimer’s Disease25
Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs) During Pregnancy and the Risk for Autism spectrum disorder (ASD) and Attention deficit hyperact24
Targeting S100B Protein as a Surrogate Biomarker and its Role in Various Neurological Disorders24
Depression and Pain: Use of Antidepressants24
Tetrahydrobioterin (BH4) Pathway: From Metabolism to Neuropsychiatry23
Traumatic Brain Injury: A Forensic Approach: A Literature Review23
New Mechanisms and Targets of Subarachnoid Hemorrhage: A Focus on Mitochondria22
Neuroinflammation in Huntington’s Disease: A Starring Role for Astrocyte and Microglia22
Acid-Sensing Ion Channels: Focus on Physiological and Some Pathological Roles in the Brain22
Neuropharmacological and Neurogenetic Correlates of Opioid Use Disorder (OUD) As a Function of Ethnicity: Relevance to Precision Addiction Medicine21
cGAS-STING-mediated IFN-I Response in Host Defense and Neuroinflammatory Diseases21
Current and Future Neuropharmacological Options for the Treatment of Essential Tremor20
SIRT1 Promotes Neuronal Fortification in Neurodegenerative Diseases through Attenuation of Pathological Hallmarks and Enhancement of Cellular Lifespan19
MicroRNAs: The New Challenge for Traumatic Brain Injury Diagnosis19
Neurodegenerative Pathways in Alzheimer’s Disease: A Review19
Emerging Evidence for Neuropsycho-Consequences of COVID-1919
Endocannabinoid Receptors in the CNS: Potential Drug Targets for the Prevention and Treatment of Neurologic and Psychiatric Disorders19
Gut Microbiota Regulate Astrocytic Functions in the Brain: Possible Therapeutic Consequences18
Pharmacological and Non-pharmacological Treatments of Sleep Disorders in Parkinson's Disease18
An Overview on Chemotherapy-induced Cognitive Impairment and Potential Role of Antidepressants18
Role of Hydrogen Sulfide and Polysulfides in Neurological Diseases: Focus on Protein S-Persulfidation18
The Links between Cardiovascular Diseases and Alzheimer's Disease18
Elucidating the Potential Side Effects of Current Anti-Seizure Drugs for Epilepsy18
The Updated Role of the Blood Brain Barrier in Subarachnoid Hemorrhage: From Basic and Clinical Studies18
Interaction between Zinc, GPR39, BDNF and Neuropeptides in Depression17
Inhibition of Caspase 3 and Caspase 9 Mediated Apoptosis: A Multimodal Therapeutic Target in Traumatic Brain Injury17
Circadian Rhythm Disruption and Alzheimer’s Disease: The Dynamics of a Vicious Cycle17
Sleep Disturbances and Cognitive Impairment in the Course of Type 2 Diabetes-A Possible Link17
Behavioral Tasks Evaluating Schizophrenia-like Symptoms in Animal Models: A Recent Update17
Molecular Mechanism of Autophagy: Its Role in the Therapy of Alzheimer’s Disease17
Current Understanding of Central Nervous System Drainage Systems: Implications in the Context of Neurodegenerative Diseases17
PLGA-Based Curcumin Delivery System: An Interesting Therapeutic Approach in the Treatment of Alzheimer’s Disease17
Tyrosol as a Neuroprotector: Strong Effects of a “Weak” Antioxidant16
Synthetic Cannabinoids and Cathinones Cardiotoxicity: Facts and Perspectives16
Recent Trends in the Management of Alzheimer’s Disease: Current Therapeutic Options and Drug Repurposing Approaches16
Neural Substrates for the Regulation of Sleep and General Anesthesia16
Current Status of Drug Targets and Emerging Therapeutic Strategies in the Management of Alzheimer's Disease16
Autophagy & Phagocytosis in Neurological Disorders and their Possible Cross-talk16
MicroRNAs in the Blood-Brain Barrier in Hypoxic-Ischemic Brain Injury16
The Dawn of Mitophagy: What Do We Know by Now?16
Anti-IL-6 Therapies for Neuromyelitis Optica Spectrum Disorders: A Systematic Review of Safety and Efficacy16
The e-Psychonauts’ ‘Spiced’ World; Assessment of the Synthetic Cannabinoids’ Information Available Online15
From the Molecular Mechanism to Pre-clinical Results: Anti-epileptic Effects of Fingolimod15
The Ambiguous Role of Microglia in Aβ Toxicity: Chances for Therapeutic Intervention15
Neuroprotective Potential of Caffeic Acid Phenethyl Ester (CAPE) in CNS Disorders: Mechanistic and Therapeutic Insights15
Chlorogenic Acid Improves PTSD-like Symptoms and Associated Mechanisms15
Biomedical Perspectives of Acute and Chronic Neurological and Neuropsychiatric Sequelae of COVID-1915
Nerve Growth Factor in Alcohol Use Disorders15
Effects of General Anesthetics on Synaptic Transmission and Plasticity14
Progression in Moyamoya Disease: Clinical Features, Neuroimaging Evaluation, and Treatment14
Expanding the Arsenal Against Huntington's Disease-Herbal Drugs and Their Nanoformulations14
Targeting Brain-spleen Crosstalk After Stroke: New Insights Into Stroke Pathology and Treatment14
Is It the Twilight of BACE1 Inhibitors?14
Use of Phenytoin, Phenobarbital Carbamazepine, Levetiracetam Lamotrigine and Valproate in Pregnancy and Breastfeeding: Risk of Major Malformations, Dose-dependency, Monotherapy vs Polytherapy, Pharmac14
Xenogeneic Decellularized Extracellular Matrix-based Biomaterials For Peripheral Nerve Repair and Regeneration14
Neuroprotective Effects of Neuropeptide Y against Neurodegenerative Disease14
A Comprehensive Review of Alzheimer’s Association with Related Proteins: Pathological Role and Therapeutic Significance14
Therapeutic Potential of Multifunctional Derivatives of Cholinesterase Inhibitors14
Src Family Kinases in the Central Nervous System: Their Emerging Role in Pathophysiology of Migraine and Neuropathic Pain13
Alzheimer’s Disease: New Concepts on the Role of Autoimmunity and NLRP3 Inflammasome in the Pathogenesis of the Disease13
Effects of Histone Modification in Major Depressive Disorder13
Role of Grina/Nmdara1 in the Central Nervous System Diseases13
Adolescent Substance Abuse, Transgenerational Consequences and Epigenetics13
A Healthy Gut for a Healthy Brain: Preclinical, Clinical and Regulatory Aspects13
Peripheral and Central Glutamate Dyshomeostasis in Neurodegenerative Disorders13
Ketogenic Diet: An Effective Treatment Approach for Neurodegenerative Diseases12
Adult Neurogenesis in Epileptogenesis: An Update for Preclinical Finding and Potential Clinical Translation12
Effects of Risperidone in Autistic Children and Young Adults: A Systematic Review and Meta-Analysis12
Targeting Glioblastoma: The Current State of Different Therapeutic Approaches12
Hydrogen Sulfide (H2S) Signaling as a Protective Mechanism against Endogenous and Exogenous Neurotoxicants12
BACE1: A Key Regulator in Alzheimer’s Disease Progression and Current Development of its Inhibitors12
Evaluation of Anti-inflammatory Nutraceuticals in LPS-induced Mouse Neuroinflammation Model: An Update12
Drug Delivery Nanosystems in Glioblastoma Multiforme Treatment: Current State of the Art12
Plant-Derived Natural Compounds for the Treatment of Amyotrophic Lateral Sclerosis: An Update12
Novel Synthetic and Natural Therapies for Traumatic Brain Injury12
Green Tea, A Medicinal Food with Promising Neurological Benefits12
Cholecystokinin-Mediated Neuromodulation of Anxiety and Schizophrenia: A “Dimmer-Switch” Hypothesis12
Neurochemical and Behavioral Consequences of Ethanol and/or Caffeine Exposure: Effects in Zebrafish and Rodents12
The Brain-gut Axis-where are we now and how can we Modulate these Connections?12
Phytochemicals Targeting Oxidative Stress, Interconnected Neuroinflammatory, and Neuroapoptotic Pathways Following Radiation12
Protective Effects of Dendrobium nobile Lindl. Alkaloids on Alzheimer's Disease-like Symptoms Induced by High-methionine Diet12
Linalool as a Therapeutic and Medicinal Tool in Depression Treatment: A Review11
Pharmacologic Treatment of Restless Legs Syndrome11
Therapeutic Strategies to Protect the Central Nervous System against Shiga Toxin from Enterohemorrhagic Escherichia coli11
Challenges of Delirium Management in Patients with Traumatic Brain Injury: From Pathophysiology to Clinical Practice11
Current and Emerging Treatments for Methamphetamine Use Disorder11
Nanotechnological Advances for Nose to Brain Delivery of Therapeutics to Improve the Parkinson Therapy11
Repetitive Transcranial Magnetic Stimulation Combined with Antidepressants for the First Episode of Major Depressive Disorder11
Modulation of Gut-Brain Axis by Probiotics: A Promising Anti-depressant Approach11
Vitamin D and Depression in Women: A Mini-review11
Phytocannabinoids: General Aspects and Pharmacological Potential in Neurodegenerative Diseases11
Effects of Di-2-Ethylhexyl Phthalate on Central Nervous System Functions: A Narrative Review11
The Complexity of Secondary Cascade Consequent to Traumatic Brain Injury: Pathobiology and Potential Treatments11
Association of Oxidative Stress with Neurological Disorders11
Pathways Involved in Remyelination after Cerebral Ischemia11
Presynaptic Release-regulating Metabotropic Glutamate Receptors: An Update10
Melatonin and Melatonergic Influence on Neuronal Transcription Factors: Implications for the Development of Novel Therapies for Neurodegenerative Disorders10
Early Biomarkers and Intervention Programs for the Infant Exposed to Prenatal Stress10
Immune Checkpoint Inhibitors and Neurotoxicity10
Microtubule-modulating Agents in the Fight Against Neurodegeneration: Will it ever Work?10
The Emerging Role of the Double-Edged Impact of Arachidonic Acid- Derived Eicosanoids in the Neuroinflammatory Background of Depression.10
Targeting the Endocannabinoid System in Borderline Personality Disorder: Corticolimbic and Hypothalamic Perspectives10
Potential Therapeutic Approaches to Alzheimer’s Disease By Bioinformatics, Cheminformatics And Predicted Adme-Tox Tools10
Depression as an Immunometabolic Disorder: Exploring Shared Pharmacotherapeutics with Cardiovascular Disease10
Role of Gut Microbiota in Multiple Sclerosis and Potential Therapeutic Implications10
Antioxidant Enzymes and Weight Gain in Drug-naive First-episode Schizophrenia Patients Treated with Risperidone for 12 Weeks: A Prospective Longitudinal Study10
Cholinesterase Inhibitory Potential of Quercetin towards Alzheimer’s Disease - A Promising Natural Molecule or Fashion of the Day? - A Narrowed Review10
Is Adult Hippocampal Neurogenesis Really Relevant for the Treatment of Psychiatric Disorders?10
The Investigation into Neurotoxicity Mechanisms of Nonylphenol: A Narrative Review9
The Therapeutic Potential and Usage Patterns of Cannabinoids in People with Spinal Cord Injuries: A Systematic Review9
Depression: An Insight into Heterocyclic and Cyclic Hydrocarbon Compounds Inspired from Natural Sources9
The Benzydamine Experience: A Systematic Review of Benzydamine Abuse9
The Potential Role of Hypoxia-Inducible Factor-1 in the Progression and Therapy of Central Nervous System Diseases9
Patients Stratification Strategies to Optimize the Effectiveness of Scavenging Biogenic Aldehydes: Towards a Neuroprotective Approach for Parkinson's Disease9
Voxel-wise Functional Connectivity of the Default Mode Network in Epilepsies: A Systematic Review and Meta-Analysis9
Melatonin as a Chronobiotic with Sleep-promoting Properties9
Targeting Ionotropic Glutamate Receptors in the Treatment of Epilepsy9
The Role of Neuroglial Metabotropic Glutamate Receptors in Alzheimer’s Disease9
Targeting Options of Tumor-Associated Macrophages (TAM) Activity in Gliomas9
Neurodevelopment Following Exposure to Antiseizure Medications in Utero: A Review9
Pharmacological Strategy for Congenital Myasthenic Syndrome with CHRNE Mutations: A Meta-Analysis of Case Reports9
The Protective Roles and Molecular Mechanisms of Troxerutin (Vitamin P4) for the Treatment of Chronic Diseases: A Mechanistic Review9
Cholinergic Modulation of General Anesthesia9
Protective Effects of Polydatin Against Dementia-Related Disorders9
Comparative Analysis of the Pre- and Post-Medication Effects of Antipsychotic Agents on the Blood-Based Oxidative Stress Biomarkers in Patients with Schizophrenia: A Meta-Analysis9
Effects of Mulberry on The Central Nervous System: A Literature Review9
The Role of Astrogliosis in Formation of the Syrinx in Spinal Cord Injury9
Interplay of BDNF and GDNF in the Mature Spinal Somatosensory System and Its Potential Therapeutic Relevance9
What About Drug Checking? Systematic Review and Netnographic Analysis of Social Media9
Beyond its Psychiatric Use: The Benefits of Low-dose Lithium Supplementation9
siRNA Therapeutics: Future Promise for Neurodegenerative Diseases9
Crocus Sativus L. (Saffron) in Alzheimer’s Disease Treatment: Bioactive Effects on Cognitive Impairment9
Pharmacological Effects of Saffron and its Constituents in Ocular Disorders from in vitro Studies to Clinical Trials: A Systematic Review8
Modulating Gut Microbiota: An Emerging Approach in the Prevention and Treatment of Multiple Sclerosis8
Dapsone, More than an Effective Neuro and Cytoprotective Drug8
The Lymphatic System In The Brain Clearance Mechanisms - New Therapeutic Perspectives For Alzheimer's Disease8
Therapeutic Potential of Ultrasound Neuromodulation in Decreasing Neuropathic Pain: Clinical and Experimental Evidence8
Advances in the Pharmacological and Non-pharmacological Management of Non-motor Symptoms in Parkinson’s Disease: An Update Since 20178
Sceletium for Managing Anxiety, Depression and Cognitive Impairment: A Traditional Herbal Medicine in Modern-Day Regulatory Systems8
Transgenerational Abnormalities Induced by Paternal Preconceptual Alcohol Drinking: Findings from Humans and Animal Models8
Use of Zebrafish Genetic Models to Study Etiology of the Amyloid-Beta and Neurofibrillary Tangle Pathways in Alzheimer's Disease8
Targeting the Neuronal Activity of Prefrontal Cortex: New Directions for the Therapy of Depression8
C-terminus of Hsp70 Interacting Protein (CHIP) and Neurodegeneration: Lessons from the Bench and Bedside8
Sex-Specific Association between Antioxidant Defense System and Therapeutic Response to Risperidone in Schizophrenia: A Prospective Longitudinal Study8
Hexahydrocannabinol Pharmacology, Toxicology, and Analysis: The First Evidence for a Recent New Psychoactive Substance8
Treatment of Circadian Rhythm Sleep–Wake Disorders8
How to Optimize the Effectiveness and Safety of Parkinson’s Disease Therapy? – A Systematic Review of Drugs Interactions with Food and Dietary Supplements8
Natural Product-based Nanomedicine: Recent Advances and Issues for the Treatment of Alzheimer's Disease8
Fabry Disease: Current and Novel Therapeutic Strategies. A Narrative Review8
Putative Roles of Astrocytes in General Anesthesia8
The Role of Natural Products in Treatment of Depressive Disorder7
The Effects and Underlying Mechanisms of Cell Therapy on Blood-Brain Barrier Integrity After Ischemic Stroke7
The Wistar Kyoto Rat: A Model of Depression Traits7
Overcoming the Challenges of Detecting GPCR Oligomerization in the Brain7
Human Dermal Fibroblast: A Promising Cellular Model to Study Biological Mechanisms of Major Depression and Antidepressant Drug Response7
The Role of Stem Cells in the Therapy of Stroke7
Galectin-3 in Microglia-Mediated Neuroinflammation: Implications for Central Nervous System Diseases7
From Hybrids to New Scaffolds: The Latest Medicinal Chemistry Goals in Multi-target Directed Ligands for Alzheimer’s Disease7
Epigenetic Landscape of Methamphetamine Use Disorder7
Study of Nutraceuticals and Phytochemicals for the Management of Alzheimer's Disease: A Review7
The Safety and Efficacy of Botanicals with Nootropic Effects7
GABAB Receptors: are they Missing in Action in Focal Epilepsy Research?7
Serine Proteases and Chemokines in Neurotrauma: New Targets for Immune Modulating Therapeutics in Spinal Cord Injury7
Stem Cell-based Therapeutic and Diagnostic Approaches in Alzheimer's Disease7
Non-canonical Molecular Targets for Novel Analgesics: Intracellular Calcium and HCN Channels7
7,8-Dihydroxyflavone and Neuropsychiatric Disorders: A Translational Perspective from the Mechanism to Drug Development7
Mimicking Extracellular Matrix via Engineered Nanostructured Biomaterials for Neural Repair7
Biomarkers and Tools for Predicting Alzheimer’s Disease in the Preclinical Stage7
Receptors for Advanced Glycation End Products (RAGE): Promising Targets Aiming at the Treatment of Neurodegenerative Conditions7
The Effect of Melatonin Modulation of Non-coding RNAs on Central Nervous System Disorders: An Updated Review7
Association Between the COMT Val158Met Polymorphism and Antipsychotic Efficacy in Schizophrenia: An Updated Meta-Analysis7
Post-Translational Modifications of BACE1 in Alzheimer's Disease7
Poloxamer 188 (P188), A Potential Polymeric Protective Agent for Central Nervous System Disorders: A Systematic Review7
The Role of Voltage-Gated Calcium Channels in Basal Ganglia Neurodegenerative Disorders6
The Role of Mitochondria-Targeting miRNAs in Intracerebral Hemorrhage6
In Vitro, In Vivo and Ex Vivo Models for Peripheral Nerve Injury and Regeneration6
Involvement of the Renin-Angiotensin System in Stress: State of the Art and Research Perspectives6
Ameliorating Alzheimer’s-like Pathology by Minocycline via Inhibiting Cdk5/p25 Signaling6
Crosstalk between Microglia and Neurons in Neurotrauma: An Overview of the Underlying Mechanisms6
Prospective Investigation of Glutamate Levels and Percentage Gray Matter in the Medial Prefrontal Cortex in Females at Risk for Postpartum Depression6
Nanocarrier-Based Drug Delivery to Brain: Interventions of Surface Modification6
Homocysteinylation and Sulfhydration in Diseases6
Neutrophil Heterogeneity and its Roles in the Inflammatory Network after Ischemic Stroke6
Epigenetic Mechanisms Mediate Nicotine-Induced Reward and Behaviour in Zebrafish6
Invasive and Non-Invasive Electrical Neuromodulation in Trigeminal Nerve Neuralgia: A Systematic Review and Meta-Analysis6
Progress and Promise of Nur77-based Therapeutics for Central Nervous System Disorders6
Uncoupling Protein 2 as a Pathogenic Determinant and Therapeutic Target in Cardiovascular and Metabolic Diseases6
Nanotherapeutics in Neuropathologies: Obstacles, Challenges and Recent Advancements in CNS Targeted Drug Delivery Systems6
Traumatic Internal Carotid Artery Injuries: Do We Need a Screening Strategy? Literature Review, Case Report, and Forensic Evaluation6
Transcriptional Factors and Protein Biomarkers as Target Therapeutics in Traumatic Spinal Cord and Brain Injury6
Mitochondrial Medicine: A Promising Therapeutic Option Against Various Neurodegenerative Disorders6
Crosstalk Between Covid-19 and Associated Neurological Disorders: A Review6
Mechanism of Curcuma longa and Its Neuroactive Components for the Management of Epileptic Seizures: A Systematic Review6
Glutamate NMDA Receptor Antagonists with Relevance to Schizophrenia: A Review of Zebrafish Behavioral Studies6
Changes in Histaminergic System in Neuropsychiatric Disorders and the Potential Treatment Consequences6
Resveratrol-Mediated Regulation of Mitochondria Biogenesis-associated Pathways in Neurodegenerative Diseases: Molecular Insights and Potential Therapeutic Applications6
Naturally Inspired Pyrimidines Analogues for Alzheimer’s Disease6
The Pathogenesis of Neurotrauma Indicates Targets for Neuroprotective Therapies6
Drugs Used in the Treatment of Multiple Sclerosis During COVID-19 Pandemic: A Critical Viewpoint5
Epilepsy and Autism Spectrum Disorder (ASD): The Underlying Mechanisms and Therapy Targets Related to Adenosine5
Cholesterol in Brain Development and Perinatal Brain Injury: More than a Building Block5
Putative Involvement of Endocrine Disruptors in the Alzheimer's Disease Via the Insulin-Regulated Aminopeptidase/GLUT4 Pathway5
Implication of Hippocampal Neurogenesis in Autism Spectrum Disorder: Pathogenesis and Therapeutic Implications5
The NLRP3 Inflammasome in Stress Response: Another Target for the Promiscuous Cannabidiol5
The Effects of Drugs used for the Treatment of Attention Deficit Hyperactivity Disorder (ADHD) on Pregnancy Outcome and Breast-feeding: A Critical Review5
Sleep, Narcolepsy, and Sodium Oxybate5
Design Strategies, Chemistry and Therapeutic Insights of Multi-target Directed Ligands as Antidepressant Agents5
The Astrogenic Balance in the Aging Brain5
0.063930988311768